Influenza vaccination and myocarditis among patients receiving immune checkpoint inhibitors.

Awadalla M, Golden DLA, Mahmood SS, Alvi RM, Mercaldo ND, Hassan MZO, Banerji D, Rokicki A, Mulligan C, Murphy SPT, Jones-O'Connor M, Cohen JV, Heinzerling LM, Armanious M, Sullivan RJ, Damrongwatanasuk R, Chen CL, Gupta D, Kirchberger MC, Moslehi JJ, Shah SP, Ganatra S, Thavendiranathan P, Rizvi MA, Sahni G, Lyon AR, Tocchetti CG, Mercurio V, Thuny F, Ederhy S, Mahmoudi M, Lawrence DP, Groarke JD, Nohria A, Fradley MG, Reynolds KL, Neilan TG
J Immunother Cancer. 2019 7 (1): 53

PMID: 30795818 · PMCID: PMC6387531 · DOI:10.1186/s40425-019-0535-y

MeSH Terms (13)

Aged Aged, 80 and over Antineoplastic Agents, Immunological Female Humans Influenza, Human Influenza Vaccines Male Middle Aged Myocarditis Neoplasms Registries Vaccination

Connections (1)

This publication is referenced by other Labnodes entities: